Butaperazine
![]()  | |
| Clinical data | |
|---|---|
| ATC code | |
| Legal status | |
| Legal status | 
  | 
| Identifiers | |
IUPAC name 
  | |
| CAS Number | 
  | 
| PubChem CID | |
| DrugBank | |
| ChemSpider | 
  | 
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.010.450 | 
| Chemical and physical data | |
| Formula | C24H31N3OS | 
| Molar mass | 409.59 g·mol−1 | 
| 3D model (JSmol) | |
SMILES 
  | |
InChI 
  | |
| (verify) | |
Butaperazine (Repoise, Tyrylen) is a typical antipsychotic of the phenothiazine class.[2] It was approved in 1967, and possibly discontinued in the 1980s.
Synthesis

Patent:[3]
2-Butyrylphenothiazine [25244-91-1] (1) is the requisite starting material for carrying out the procedure. It is prepared in a manner that is synonymous with the method used in the propiomazine and propiopromazine already discussed. The 1-(γ-chloropropyl)-4-methylpiperazine [104-16-5] (2) is prepared in the conventional way from alkylating 1-methylpiperazine and 1-Bromo-3-chloropropane. Sodamide is used to extract the 10-H thereby facilitating the nucleophilic substitution reaction. And completing the instalment of the sidechain.
See also
References
- ↑ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
 - ↑ "Evaluation of a new antipsychotic agent. Butaperazine maleate (repoise maleate)". JAMA. 206 (10): 2307–8. December 1968. doi:10.1001/jama.206.10.2307. PMID 4386884.
 - ↑ Dr Ulrich Hoerlein, Dr Klaus-Heinz Risse, Dr Wolfgang Wirth, DE 1120451 (1961 to Bayer Ag).
 
| Typical | 
 
  | 
|---|---|
| Disputed | |
| Atypical | 
 
 
  | 
| Others | 
  | 
  | |
Acetylcholine receptor modulators  | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 
  | |||||||||||||||||||||||||
| D1-like | 
  | ||||||
|---|---|---|---|---|---|---|---|
| D2-like | 
  | ||||||
  | |||||||
Histamine receptor modulators  | |||||
|---|---|---|---|---|---|
| H1 | 
  | ||||
| H2 | 
  | ||||
| H3 | 
  | ||||
| H4 | 
  | ||||
  | |||||
| Classes | 
  | 
|---|---|
| Antidepressants (Tricyclic antidepressants (TCAs))  | 
  | 
| Antihistamines | 
  | 
| Antipsychotics | 
  | 
| Anticonvulsants | |
| Anticholinergics | |
| Others | 
  | 
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
